President & CEO
Mr. Buckman has served as CEO and board member of Conventus Orthopaedics since September 2013. Prior to Conventus, Mr. Buckman also held CEO roles at SentreHeart, Inc. (continues as Director), Pathway Medical Technologies (sold to Bayer Healthcare in 2011), and Devax, Inc. (sold to Biosensors International). From 2004 though 2006, Mr. Buckman served as President of the Cardiology Division of St. Jude Medical, Inc., a diversified medical products company. Prior to joining St. Jude Medical, Mr. Buckman served as Chairman of the board of directors and CEO of ev3, LLC, a Minnesota-based cardiovascular device company that Mr. Buckman co – founded (acquired by Covidien for $2.5B in 2010). Mr. Buckman has worked in the medical device industry for 35 years, including 10 years at Scimed Life Systems, Inc. and Boston Scientific Corporation, where he held several executive positions before becoming President of the Cardiology Division of Boston Scientific in January 2000. Mr. Buckman currently serves on the Boards of Conventus Orthopaedics, SentreHeart, Inc., Sunshine Heart, Inc., and Caisson Interventional. In the past, Mr. Buckman has also served on the boards of Devax, Pathway Medical, ev3, Velocimed, where he was a Co-Founder, EndiCor, Microvena, and Micro Therapeutics. Mr. Buckman received a B.A. degree in Business Administration and an MBA degree from Western Michigan University.